Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pediatrics
Volume 2012 (2012), Article ID 193093, 4 pages
http://dx.doi.org/10.1155/2012/193093
Case Report

Successful Treatment of Acute Lymphoblastic Leukemia in a Child with Trisomy 21 and Complex Congenital Heart Disease with Mechanical Prosthetic Valve

1Division of Pediatric Oncology, Hematology and BMT, Department of Pediatrics, British Columbia’s Children’s Hospital, University of British Columbia, 4480 Oak Street, Vancouver, BC, Canada V6H 3V4
2Department of Pediatrics, Oregon Health & Science University, Portland, OR 97239, USA
3Division of Pediatric Interventional Radiology, Children’s and Women’s Health Center of British Columbia, University of British Columbia, Vancouver, BC, Canada V6H 3V4
4Division of Pediatric Cardiology, Department of Pediatrics, British Columbia’s Children’s Hospital, University of British Columbia, Vancouver, BC, Canada V6H 3V4

Received 29 June 2012; Accepted 28 July 2012

Academic Editors: E. De Vries and H. Horigome

Copyright © 2012 Saima Alvi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Möricke, M. Zimmermann, A. Reiter et al., “Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000,” Leukemia, vol. 24, no. 2, pp. 265–284, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. A. C. Xavier, Y. Ge, and J. W. Taub, “Down syndrome and malignancies: a unique clinical relationship—a paper from the 2008 William Beaumont Hospital symposium on molecular pathology,” Journal of Molecular Diagnostics, vol. 11, no. 5, pp. 371–380, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. J. T. Wiernikowski and U. H. Athale, “Thromboembolic complications in children with cancer,” Thrombosis Research, vol. 118, no. 1, pp. 137–152, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Newall, P. Monagle, and L. Johnston, “Home INR monitoring of oral anticoagulant therapy in children using the CoaguChek S point-of-care monitor and a robust education program,” Thrombosis Research, vol. 118, no. 5, pp. 587–593, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Elhasid, N. Lanir, R. Sharon et al., “Prophylactic therapy with enoxaparin during L-asparaginase treatment in children with acute lymphoblastic leukemia,” Blood Coagulation and Fibrinolysis, vol. 12, no. 5, pp. 367–370, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. U. Nowak-Göttl, N. Münchow, U. Klippel et al., “The course of fibrinolytic proteins in children with malignant bone tumours,” European Journal of Pediatrics, Supplement, vol. 158, supplement 3, pp. S151–S153, 1999. View at Google Scholar · View at Scopus
  7. D. N. Salem, P. T. O'Gara, C. Madias, and S. G. Pauker, “Valvular and structural heart disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition),” Chest, vol. 133, supplement 6, pp. 593S–629S, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. R. O. Bonow, B. A. Carabello, K. Chatterjee et al., “2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular,” Circulation, vol. 118, no. 15, pp. e523–e661, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. P. R. Daniels, R. D. McBane, S. C. Litin et al., “Peri-procedural anticoagulation management of mechanical prosthetic heart valve patients,” Thrombosis Research, vol. 124, no. 3, pp. 300–305, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. S. M. Bates, I. A. Greer, I. Pabinger, S. Sofaer, and J. Hirsh, “Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition),” Chest, vol. 133, supplement 6, pp. 844S–886S, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. C. J. Eskey and C. S. Ogilvy, “Fluoroscopy-guided lumbar puncture: decreased frequency of traumatic tap and implications for the assessment of CT-negative acute subarachnoid hemorrhage,” American Journal of Neuroradiology, vol. 22, no. 3, pp. 571–576, 2001. View at Google Scholar · View at Scopus
  12. A. S. D. Spiers and R. S. Mibashan, “Increased warfarin requirement during mercaptopurine therapy: a new drug interaction,” The Lancet, vol. 2, no. 7874, pp. 221–222, 1974. View at Google Scholar · View at Scopus
  13. M. Rotenberg, Y. Levy, Y. Shoenfeld, S. Almog, and D. Ezra, “Effect of azathioprine on the anticoagulant activity of warfarin,” The Annals of Pharmacotherapy, vol. 34, no. 1, pp. 120–122, 2000. View at Google Scholar · View at Scopus
  14. G. Rivier, M. A. Khamashta, and G. R. V. Hughes, “Warfarin and azathioprine: a drug interaction does exist,” American Journal of Medicine, vol. 95, no. 3, article 342, 1993. View at Google Scholar · View at Scopus
  15. J. D. Singleton and L. Conyers, “Warfarin and azathioprine: an important drug interaction,” American Journal of Medicine, vol. 92, no. 2, article 217, 1992. View at Google Scholar · View at Scopus
  16. E. C. van Dalen, M. F. Raphaël, H. N. Caron, and L. C. Kremer, “Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer,” Cochrane Database of Systematic Reviews, vol. 1, Article ID CD006647, 2011. View at Google Scholar · View at Scopus